US Stock Benchmarks are sending mixed signals despite positive CPI report. Traders will await for further clues and news in order to move forward. Read more here.

Discover asymmetric value opportunities in CSL and PGR: strong moats, attractive valuations, and dividend yield.

MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group ...

The Federal Government has pledged to integrate eye health into youth development policies and programmes to curb poor ...